Paz-Ares L, et al. Overall survival with durvalumab plus etoposide-platinum in first-line extensive-stage SCLC: results from the CASPIAN study. Abstract PL02.11. WCLC 2019, 7-10 september, Barcelona, Spanje.
Web tool meet DNA-reparatie
apr 2019
feb 2024
dec 2023 | Uro-oncologie
dec 2022 | Maag-darm-leveroncologie
jun 2021 | Chirurgie, Maag-darm-leveroncologie
feb 2021 | Maag-darm-leveroncologie
jul 2024
jun 2024
mrt 2024
nov 2023